More tools:Markets·Screener·Research·Chat

CorMedix Inc. (CRMD) Financial Statements

CorMedix Inc.
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001T6FWS5
XNAS · usd
8.18▼ 0.25 (-2.97%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close8.43
Day's Range8.11 – 8.37
52-Week Range6.12 – 13.83
Volume1.1M
Avg Volume1.3M
Share Statistics
Shares Outstanding
Employees191
ExchangeXNAS
Listed2010-05-13
Share count as of August 10, 2026
Loading Income Statement…
Key questions about CorMedix Inc. (CRMD)
What is CorMedix Inc.'s Market Cap?
CorMedix Inc.'s Market Cap is $637.6M, based on as-reported figures from SEC (XBRL) filings.
What is CorMedix Inc.'s Enterprise Value?
CorMedix Inc.'s Enterprise Value is $380.9M, based on as-reported figures from SEC (XBRL) filings.
What is CorMedix Inc.'s Trailing P/E?
CorMedix Inc.'s Trailing P/E is 3.4×, based on as-reported figures from SEC (XBRL) filings.
What is CorMedix Inc.'s Price / Sales?
CorMedix Inc.'s Price / Sales is 2.0×, based on as-reported figures from SEC (XBRL) filings.
What is CorMedix Inc.'s EV / Revenue?
CorMedix Inc.'s EV / Revenue is 1.2×, based on as-reported figures from SEC (XBRL) filings.
What is CorMedix Inc.'s EV / EBITDA?
CorMedix Inc.'s EV / EBITDA is 1.7×, based on as-reported figures from SEC (XBRL) filings.
What is CorMedix Inc.'s Revenue (TTM)?
CorMedix Inc.'s Revenue (TTM) is $311.7M, based on as-reported figures from SEC (XBRL) filings.
What is CorMedix Inc.'s Net Income (TTM)?
CorMedix Inc.'s Net Income (TTM) is $187.2M, based on as-reported figures from SEC (XBRL) filings.
What is CorMedix Inc.'s EBITDA?
CorMedix Inc.'s EBITDA is $231.6M, based on as-reported figures from SEC (XBRL) filings.
What is CorMedix Inc.'s Diluted EPS (TTM)?
CorMedix Inc.'s Diluted EPS (TTM) is 2.40, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue and Grant Income:
Total Revenue and Grant Income——
YoY growth+156.5%+226.1%——
Cost of sales (exclusive of amortization of intangibles)
Amortization of intangibles
Gross profit
% of revenue75.7%82.5%——
Operating Expenses:
Research and development
Selling and marketing
General and administrative
Total Operating Expenses
% of revenue33.6%32.5%——
Income From Operations
% of revenue42.1%50.0%——
Other (Expense) Income:
Unrealized gain (loss) on marketable equity security
Change in contingent consideration
Other non-operating (expense) income, net——
Total Other (Expense) Income
Income before income taxes
Tax expense
Net Income
% of revenue25.5%30.3%——
Net Income Per Common Share – Basic (in dollars per share)—
Net Income Per Common Share - Diluted (in dollars per share)—